DRI Digoxin Assay

Hazard statements (CLP)

H315, H317, H319, H334

Code

Statements

H315

Causes skin irritation

2.1 Classification of the substance or mixture

Globally Harmonized Skin sensitizer - Category 1. Respiratory sensitizer - Category 1. Irritant (skin) - System [GHS] Category 2. Irritant (eye) - Category 2. Other/Supplemental Mixture not yet fully tested.

2.2 Label elements

SECTION 2 - HAZARDS IDENTIFICATION …continued

Signal word

Danger

Hazard statements

H315 - Causes skin irritation. H317 - May cause allergic skin reaction. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective gloves/eye protection/face protection. P285 - In case of inadequate ventilation wear respiratory protection. P302 + P352 - If on skin Wash with plenty of soap and water. P304 + P341 - IF INHALED If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 - Specific treatment (see First Aid information on product label and/or Section 4 of the SDS). P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention. P337 + P313 - If eye irritation persists: Get medical advice/attention. P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P363 - Wash contaminated clothing before reuse. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations.

Precautionary statements

P261 - Avoid breathing mist or vapor. P264 - Wash hands thoroughly after

2.3 Other hazards

The potential health hazards associated with exposure/handling of this mixture are unknown; no data specific for the mixture were identified. The following data describe the hazards of individual ingredients, where applicable. This product contains human source material (human serum albumin) and should be treated/handled as a potential biohazard. All such human source material has been derived from donors tested individually and shown by FDA approved methods to be free from antibodies to Human Immune Deficiency Virus and Hepatitis B and C. As no test method can offer complete assurance that these or other infectious agents are not present, this product should be handled using standard biosafety precautions. As the product/mixture contains a protein/antibody from a foreign animal source, significant exposure may cause an allergic skin or respiratory reaction (e.g., potential to cause anaphylaxis). In a workplace setting, the likelihood of systemic effects following accidental ingestion is low, due to the rapid breakdown of proteins in the digestive tract. Although antibody particles are fairly large proteins, it is not known if systemic effects can occur following accidental inhalation. Proteins, in general, can cause skin and/or respiratory sensitization. Note This mixture is classified as hazardous according to Regulation EC No 1272/2008 (EU CLP) and Hazard Communication Standard No. 1910.1200 (US OSHA). The pharmacological, toxicological and ecological properties of this mixture have not been fully characterized.